The Structural Characterization of Tumor Fusion Genes and Proteins

Comput Math Methods Med. 2015:2015:912742. doi: 10.1155/2015/912742. Epub 2015 Aug 10.

Abstract

Chromosomal translocation, which generates fusion proteins in blood tumor or solid tumor, is considered as one of the major causes leading to cancer. Recent studies suggested that the disordered fragments in a fusion protein might contribute to its carcinogenicity. Here, we investigated the sequence feature near the breakpoints in the fusion partner genes, the structure features of breakpoints in fusion proteins, and the posttranslational modification preference in the fusion proteins. Results show that the breakpoints in the fusion partner genes have both sequence preference and structural preference. At the sequence level, nucleotide combination AG is preferred before the breakpoint and GG is preferred at the breakpoint. At the structural level, the breakpoints in the fusion proteins prefer to be located in the disordered regions. Further analysis suggests the phosphorylation sites at serine, threonine, and the methylation sites at arginine are enriched in disordered regions of the fusion proteins. Using EML4-ALK as an example, we further explained how the fusion protein leads to the protein disorder and contributes to its carcinogenicity. The sequence and structural features of the fusion proteins may help the scientific community to predict novel breakpoints in fusion genes and better understand the structure and function of fusion proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Breakpoints
  • Computer Simulation
  • Databases, Genetic
  • Humans
  • Models, Molecular
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Oncogene Fusion*
  • Oncogene Proteins, Fusion / chemistry*
  • Oncogene Proteins, Fusion / genetics*
  • Oncogene Proteins, Fusion / metabolism
  • Protein Processing, Post-Translational
  • Translocation, Genetic

Substances

  • EML4-ALK fusion protein, human
  • Oncogene Proteins, Fusion